SNAP5089 is a selective alpha1A-adrenoceptor antagonist with over 1700-fold selectivity for the alpha1A subtype, which may have implications for the treatment of hypertension and benign prostatic hypertrophy. SNAP5089 demonstrates significant receptor affinity compared to other clinical drugs, emphasizing its potential therapeutic advantages. SNAP5089s high affinity aligns with its suitability for conditions where precise alpha1A modulation is desirable.
Molekulargewicht:
608.73
CAS Nummer:
[157066-76-7]
Formel:
C36H40N4O5
Target-Kategorie:
Adrenergic Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
